Billault Claire, Chartier-Kastler Emmanuel, Rouprêt Morgan, Robain Gilberte, Phé Véronique
Pitié-Salpêtrière Academic Hospital, Department of Urology, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris 6 University, 47-83 Boulevard de l'Hopital, 75651, Paris Cedex 13, France.
Rothschild Hospital, Department of Physical Medicine and Rehabilitation, Assistance Publique-Hôpitaux de Paris, Pierre and Marie Curie Medical School, Paris 6 University, Paris, France.
World J Urol. 2015 Nov;33(11):1897-903. doi: 10.1007/s00345-015-1520-9. Epub 2015 Feb 21.
To determine the functional outcomes of adjustable continence therapy (ACT™) balloons in elderly women suffering from stress urinary incontinence (SUI) caused by intrinsic sphincter deficiency (ISD).
A monocentric retrospective study included all non-neurological women aged >80 years who suffered from SUI due to ISD and undergoing ACT™ balloon placement between 2000 and 2013. Early post-operative complications were reported according to the Clavien-Dindo classification. Continence was assessed subjectively by the patients.
A total of 52 female patients were included, median age 83 years (IQR 81-85). Among them, 35 (67.3 %) had already undergone previous surgery for SUI. Balloon implantations were achieved under local anaesthesia for 33 (63.5 %) patients. Clavien grade I-II early post-operative complications occurred in five (9.6 %) patients. Median follow-up was 10.5 months (IQR 3-24.25). Eleven patients (21.1 %) were lost to follow-up. At last follow-up, seven patients (13.5 %) declared themselves fully continent after the first implantation, 13 patients (25 %) had an >80 % improvement rate (10 patients after first implantation, two after second implantation and one after third implantation). Four patients (7.7 %) found the procedure unsuccessful even after several consecutive implantations. Ten patients (19.2 %) reported a partial result and were still having successive balloon inflations. Explantation occurred in 22 patients, caused by infection, erosion or balloon migration. In intention-to-treat analysis, the failure rate was 42.3 %.
Although the success rate of ACT™ balloons in women aged >80 years is lower than that reported for younger women, it remains satisfactory because these patients would not otherwise have benefited from another surgical treatment.
确定可调节控尿疗法(ACT™)球囊对因固有括约肌缺陷(ISD)导致压力性尿失禁(SUI)的老年女性的功能结局。
一项单中心回顾性研究纳入了2000年至2013年间所有年龄大于80岁、因ISD患有SUI且接受ACT™球囊置入术的非神经源性女性。根据Clavien-Dindo分类报告早期术后并发症。由患者主观评估控尿情况。
共纳入52例女性患者,中位年龄83岁(四分位间距81 - 85岁)。其中,35例(67.3%)既往已接受过SUI手术。33例(63.5%)患者在局部麻醉下完成球囊植入。5例(9.6%)患者出现Clavien I-II级早期术后并发症。中位随访时间为10.5个月(四分位间距3 - 24.25个月)。11例患者(21.1%)失访。在最后一次随访时,7例患者(13.5%)在首次植入后自述完全控尿,13例患者(25%)改善率超过80%(10例在首次植入后,2例在第二次植入后,1例在第三次植入后)。4例患者(7.7%)即使在连续多次植入后仍认为手术不成功。10例患者(19.2%)报告有部分效果,仍在相继进行球囊充盈。22例患者因感染、侵蚀或球囊移位而取出球囊。在意向性分析中,失败率为42.3%。
尽管ACT™球囊在80岁以上女性中的成功率低于年轻女性的报道,但仍令人满意,因为这些患者若不接受该手术无法从其他手术治疗中获益。